Cargando…
PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis
The controlled release of active substances—bone morphogenetic protein 2 (BMP-2) and 17β-estradiol—is one of the main aspects to be taken into account to successfully regenerate a tissue defect. In this study, BMP-2- and 17β-estradiol-loaded microspheres were combined in a sandwich-like system forme...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956377/ https://www.ncbi.nlm.nih.gov/pubmed/31817033 http://dx.doi.org/10.3390/pharmaceutics11120648 |
_version_ | 1783487142296551424 |
---|---|
author | García-García, Patricia Reyes, Ricardo Segredo-Morales, Elisabet Pérez-Herrero, Edgar Delgado, Araceli Évora, Carmen |
author_facet | García-García, Patricia Reyes, Ricardo Segredo-Morales, Elisabet Pérez-Herrero, Edgar Delgado, Araceli Évora, Carmen |
author_sort | García-García, Patricia |
collection | PubMed |
description | The controlled release of active substances—bone morphogenetic protein 2 (BMP-2) and 17β-estradiol—is one of the main aspects to be taken into account to successfully regenerate a tissue defect. In this study, BMP-2- and 17β-estradiol-loaded microspheres were combined in a sandwich-like system formed by a hydrogel core composed of chitosan (CHT) collagen, 2-hidroxipropil γ-ciclodextrin (HP-γ-CD), nanoparticles of hydroxyapatite (nano-HAP), and an electrospun mesh shell prepared with two external electrospinning films for the regeneration of a critical bone defect in osteoporotic rats. Microspheres were made with poly-lactide-co-glycolide (PLGA) to encapsulate BMP-2, whereas the different formulations of 17β-estradiol were prepared with poly-lactic acid (PLA) and PLGA. The in vitro and in vivo BMP-2 delivered from the system fitted a biphasic profile. Although the in vivo burst effect was higher than in vitro the second phases (lasted up to 6 weeks) were parallel, the release rate ranged between 55 and 70 ng/day. The in vitro release kinetics of the 17β-estradiol dissolved in the polymeric matrix of the microspheres depended on the partition coefficient. The 17β-estradiol was slowly released from the core system using an aqueous release medium (D(eff) = 5.58·10(−16) ± 9.81·10(−17)m(2)s(−1)) and very fast in MeOH-water (50:50). The hydrogel core system was injectable, and approximately 83% of the loaded dose is uniformly discharged through a 20G needle. The system placed in the defect was easily adapted to the defect shape and after 12 weeks approximately 50% of the defect was refilled by new tissue. None differences were observed between the osteoporotic and non-osteoporotic groups. Despite the role of 17β-estradiol on the bone remodeling process, the obtained results in this study suggest that the observed regeneration was only due to the controlled rate released of BMP-2 from the PLGA microspheres. |
format | Online Article Text |
id | pubmed-6956377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69563772020-01-23 PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis García-García, Patricia Reyes, Ricardo Segredo-Morales, Elisabet Pérez-Herrero, Edgar Delgado, Araceli Évora, Carmen Pharmaceutics Article The controlled release of active substances—bone morphogenetic protein 2 (BMP-2) and 17β-estradiol—is one of the main aspects to be taken into account to successfully regenerate a tissue defect. In this study, BMP-2- and 17β-estradiol-loaded microspheres were combined in a sandwich-like system formed by a hydrogel core composed of chitosan (CHT) collagen, 2-hidroxipropil γ-ciclodextrin (HP-γ-CD), nanoparticles of hydroxyapatite (nano-HAP), and an electrospun mesh shell prepared with two external electrospinning films for the regeneration of a critical bone defect in osteoporotic rats. Microspheres were made with poly-lactide-co-glycolide (PLGA) to encapsulate BMP-2, whereas the different formulations of 17β-estradiol were prepared with poly-lactic acid (PLA) and PLGA. The in vitro and in vivo BMP-2 delivered from the system fitted a biphasic profile. Although the in vivo burst effect was higher than in vitro the second phases (lasted up to 6 weeks) were parallel, the release rate ranged between 55 and 70 ng/day. The in vitro release kinetics of the 17β-estradiol dissolved in the polymeric matrix of the microspheres depended on the partition coefficient. The 17β-estradiol was slowly released from the core system using an aqueous release medium (D(eff) = 5.58·10(−16) ± 9.81·10(−17)m(2)s(−1)) and very fast in MeOH-water (50:50). The hydrogel core system was injectable, and approximately 83% of the loaded dose is uniformly discharged through a 20G needle. The system placed in the defect was easily adapted to the defect shape and after 12 weeks approximately 50% of the defect was refilled by new tissue. None differences were observed between the osteoporotic and non-osteoporotic groups. Despite the role of 17β-estradiol on the bone remodeling process, the obtained results in this study suggest that the observed regeneration was only due to the controlled rate released of BMP-2 from the PLGA microspheres. MDPI 2019-12-03 /pmc/articles/PMC6956377/ /pubmed/31817033 http://dx.doi.org/10.3390/pharmaceutics11120648 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article García-García, Patricia Reyes, Ricardo Segredo-Morales, Elisabet Pérez-Herrero, Edgar Delgado, Araceli Évora, Carmen PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis |
title | PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis |
title_full | PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis |
title_fullStr | PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis |
title_full_unstemmed | PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis |
title_short | PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis |
title_sort | plga-bmp-2 and pla-17β-estradiol microspheres reinforcing a composite hydrogel for bone regeneration in osteoporosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956377/ https://www.ncbi.nlm.nih.gov/pubmed/31817033 http://dx.doi.org/10.3390/pharmaceutics11120648 |
work_keys_str_mv | AT garciagarciapatricia plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis AT reyesricardo plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis AT segredomoraleselisabet plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis AT perezherreroedgar plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis AT delgadoaraceli plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis AT evoracarmen plgabmp2andpla17bestradiolmicrospheresreinforcingacompositehydrogelforboneregenerationinosteoporosis |